4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-045688
Chief Medical Officer sold 12,500 shares at an average $50.90 ($636,222)
- Chief Medical Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2020-08-05 | Option exercise | +12,500 | $1.58 | $19,688 | 28,277 | D |
| Pang Phillip Chief Medical Officer | 2020-08-05 | Sale | −5,000 | $50.91 | $254,527 | 23,277 | D |
| Pang Phillip Chief Medical Officer | 2020-08-05 | Sale | −7,500 | $50.89 | $381,695 | 15,777 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2020-08-05 | Option exercise · Employee Stock Option (Right to Buy) | −12,500 | 85,647 | D | ||
| Open-market sales · 12,500 sh · avg $50.90 · $636,222 | |||||||
Loading xslF345X03/doc4.xml…